# Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential

> **NCT04323917** · — · UNKNOWN · sponsor: **Istituto Clinico Humanitas** · enrollment: 850 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Liquid biopsy

## Key facts

- **NCT ID:** NCT04323917
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-02
- **Primary completion:** 2021-11
- **Final completion:** 2022-11
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2020-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04323917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04323917, "Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04323917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*